 | Yahoo! Health - My Alerts - Edit Alert |
| Friday, Mar 08, 2013 11:11 AM EST | |
| Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval Fri, 08 Mar, 2013 07:58 AM PST All of these patent expirations put nearly $1.5 billion of revenues at risk. However, the month of March could bring some relief to the healthcare company as its blockbuster potential experimental drug, Canagliflozin, is expected to receive FDA approval by the end of the month. News briefs for March 8 Fri, 08 Mar, 2013 07:48 AM PST A class on diabetes support will be held from 6 p.m. to 7 p.m. Tuesday in the lower level classroom at the Boyle County Health Department. The health department is at 448 S. Third St. Danville. For more information, call Julie Steber at (859) 236-2053. Actos faces generic competition; Actos victims face cancer Fri, 08 Mar, 2013 07:46 AM PST Come to think of it, maybe it could have been a better Valentine’s Day for the leaders of Takeda Pharmaceutical Company, the maker of the type-2 diabetes drug Actos (pioglitazone). The day before, Breckenridge Pharmaceutical brass announced an inherently competitive “immediate launch of pioglitazone hydrochloride tablets,†consistent with the incipient sunset on Takeda’s Actos patent. Previously ... A*STAR scientists discover 'switch' critical to wound healing Fri, 08 Mar, 2013 07:40 AM PST Patients with diseases such as diabetes suffer from painful wounds that take a long time to heal making them more susceptible to infections that could even lead to amputations. A*STAR's discovery paves the way for therapeutics to improve healing of such chronic wounds, which are a significant burden to patients. De Zavala, Rock, Paper, Scissors Fri, 08 Mar, 2013 07:39 AM PST Amarillo, TX -Other area middle school students are raising awareness of juvenile diabetes Friday. BERLIN (dpa-AFX) â€" Nach einer Klage des Schweizer Pharmakonzerns Novartis will die Bundesregierung geplante ... Fri, 08 Mar, 2013 07:30 AM PST bei Arzneimitteln durch gesetzliche Nachbesserungen absichern. Erreicht werden soll, dass umsatzstarke Medikamente unter anderem gegen Volkskrankheiten wie Diabetes wie geplant auf ihren Nutzen bewertet werden können. Artificial pancreas outperforms insulin pump in diabetes camp Fri, 08 Mar, 2013 06:20 AM PST An artificial pancreas system proved more effective at controlling nocturnal glucose levels than a sensor-augmented insulin pump, in a study of children with Type 1 diabetes treated outside the hospital setting in a diabetes camp, report researchers. 'Healthier hormones' through diet and exercise Fri, 08 Mar, 2013 06:17 AM PST Weight loss -- by dietary changes alone or combined with physical exercise -- has a positive impact on the production of adipose tissue hormones: Adipose tissue produces less leptin but, instead, more adiponectin, which counteracts diabetes and cancer. This explains, at a molecular level, the health-promoting effect of physical exercise and dietary changes, according to researchers. Research and Markets: Gestational Diabetes Global Clinical Trials Review, H1, 2013 Fri, 08 Mar, 2013 05:06 AM PST DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/smdnq6/gestational) has announced the addition of GlobalData's new report "Gestational Diabetes Global Clinical Trials Review, H1, 2013" to their offering. Gestational Diabetes Global Clinical Trials Review, H1, 2013" provides data on the Gestational Diabetes clinical trial scenario. This report provides ... Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Cuida tu Diabetes, Cuida tu Corazon to Cook up ... prnewswire.com Fri, 08 Mar, 2013 05:00 AM PST WHITEHOUSE STATION, N.J., March 8, 2013 /PRNewswire/ -- Celebrity chef and cookbook author, Chef Leticia Moreinos Schwartz, is partnering with Merck on Cuida tu Diabetes, Cuida tu Corazon (Taking Diabetes ... | |
|
No comments:
Post a Comment